Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 3;17(1):2541828.
doi: 10.1080/20002297.2025.2541828. eCollection 2025.

Altered oral microbiome composition in mental disorders: a systematic review and meta-analysis

Dingxin Cao  1 , Jun Yang  1 , Yiwen He  1 , Xinkang Zheng  1 , Yanan Li  2 , Yadong Chen  1 , Yan Tu  1
Affiliations
Review

Altered oral microbiome composition in mental disorders: a systematic review and meta-analysis

Dingxin Cao et al. J Oral Microbiol. .

Abstract

Introduction: Emerging research underscores the gut-brain axis in mental disorder pathophysiology, yet the oral microbiome's contribution to mental health remains underexplored. Elucidating oral microbial signatures in mental and neurological disorders may reveal novel pathobiological mechanisms and advance biomarker discovery for precision diagnostics and microbiota-targeted interventions.

Methods: This systematic review and meta-analysis investigates oral microbiota alterations across 6 different mental disorders, by synthesizing data from 20 case-control studies retrieved from PubMed, Embase, and Cochrane Library. Relative microbial abundance and beta diversity indices were extracted from between-group comparisons. Random-effects meta-analyses were conducted for alpha diversity to characterize microbiota differences between patients and controls.

Results: Key findings included a significantly higher Simpson Index in patients (SMD = 0.42; 95% CI, 0.25 to 0.60) compared to controls. Beta diversity varied significantly only in SZ and MDD. Condition-specific variations in microbial abundance were observed: Rothia enrichment in ASD, overrepresentation of H2S-producing genera in SZ, and reduced Solobacterium and Leptotrichia in MDD.

Conclusion: Collectively, the meta-analytical synthesis suggests alterations in oral microbiota diversity across mental disorders. Disease-associated microbial shifts highlight the oral microbiome as a candidate factor warranting further investigation for potential diagnostic applications and microbial-targeted therapeutic strategies.

Keywords: Oral microbiota; alpha diversity; autism spectrum disorder; mental disorders; microbiome dysregulation; salivary biomarkers.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Presents the PRISMA flowchart of the study identification process.
Figure 2.
Figure 2.
Forest plots of oral microbiota alpha-diversity in patients with mental disorders versus healthy controls.
Figure 3.
Figure 3.
Sensitivity analysis forest plots of oral microbiota alpha-diversity in patients with mental disorders versus healthy controls.
Figure 4.
Figure 4.
Funnel plots of oral microbiota alpha-diversity in patients with mental disorders versus healthy controls.
Figure 5.
Figure 5.
Differences in relative abundance of microbial genera reported by at least 2 studies within a diagnostic category.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Hossain MM, Khan N, Sultana A, et al. Prevalence of comorbid psychiatric disorders among people with autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses. Psychiatry Res. 2020;287:112922. doi: 10.1016/j.psychres.2020.112922 - DOI - PubMed
    1. Kessler RC, Gruber M, Hettema JM, et al. Comorbid major depression and generalized anxiety disorders in the National comorbidity survey follow-up. Psychol Med. 2008;38(3):365–19. doi: 10.1017/S0033291707002012 - DOI - PMC - PubMed
    1. Jauhar S, Johnstone M, McKenna PJ.. Schizophrenia. Lancet. 2022;399(10323):473–486. doi: 10.1016/S0140-6736(21)01730-X - DOI - PubMed
    1. Arias D, Saxena S, Verguet S. Quantifying the global burden of mental disorders and their economic value. eClinicalmedicine. 2022;54:101675. doi: 10.1016/j.eclinm.2022.101675 - DOI - PMC - PubMed
    1. Castaldelli-Maia JM, Bhugra D. Analysis of global prevalence of mental and substance use disorders within countries: focus on sociodemographic characteristics and income levels. Int Rev Psychiatry. 2022;34(1):6–15. doi: 10.1080/09540261.2022.2040450 - DOI - PubMed

LinkOut - more resources